NPPES file of Aug 9, 2026

Godlove Ebong Etape, RPH

Pharmacist · Woodlyn, PA

Godlove Ebong Etape, RPH is a pharmacist with a practice address in Woodlyn, Pennsylvania, and NPI 1932821840, issued on Sep 16, 2022. Check the license (Pennsylvania RP453087, as entered in NPPES) with the Pennsylvania board that licenses this profession; the federal record below is the public data PlainDoctor holds for this provider.

Record from CMS NPPES, file of Aug 9, 2026 · method · Verify with CMS →

NPPES recordNPPES file of Aug 9, 2026
1932821840
Name
Godlove Ebong Etape
Credential
RPH
Primary taxonomy
Pharmacist 183500000X
License number
RP453087 PA
Self-reported in NPPES; status is on the state search
Practice location
1306 Macdade Blvd, Woodlyn, PA 19094
Phone
(610) 521-7011
Enumerated
Sep 16, 2022
Record last updated
Sep 16, 2022
Entity
Type 1 · individual
Public record from CMS NPPES (open it on the CMS NPI Registry). A record is not a license: verify it with the state board.
Download card Updates feed

Also registered at 1306 Macdade Blvd

A shared address usually means a shared clinic or building; it does not show who employs whom.

  1. Gina Decarolis, PHARMDPharmacist1164027801
  2. Randall King, PHARMDPharmacist1659956274
  3. Patience OsuagwuPharmacist1104421973

Verify Godlove Ebong Etape in five checks

  1. 1IdentityNPI record in CMS NPPESNPI lookupConfirmed in NPPES
  2. 2LicenseActive license and public ordersWhich Pennsylvania board licenses this profession
    Search for license RP453087
    Check the board
  3. 3Other statesLicenses and actions elsewhereDocInfo (FSMB)Not checked
  4. 4ExclusionsMedicare and Medicaid bansHHS-OIG exclusion listNot checked
  5. 5CertificationBoard certificationABMS AOA NCCPA AANPNot checked
Find the Pennsylvania license search

PlainDoctor does not match the HHS-OIG exclusion list to individual records: most entries carry no NPI. Search the OIG exclusion list by name.

Is this page about you? You can ask us to correct, restrict or remove it: how.

10 pharmacist records list a practice address in Woodlyn

They are 10 of the 32 NPPES records with a practice address in Woodlyn, and 13,059 pharmacist records in Pennsylvania. No Medicare prescribing, quality score, industry payment or hospital affiliation is published for this NPI.

Other pharmacist records in Pennsylvania

  1. Seth Aaron, RPHMerion Station, PA1902427453
  2. Kofi Abanquah, PHARMACISTPhiladelphia, PA1023418381
  3. Nicole AbarcaEast Stroudsburg, PA1801634662
  4. Janine AbatePittsburgh, PA1689370587
  5. Steven AbateErie, PA1619639986
  6. Sharon Abayasekara, R.PH.Camp Hill, PA1790782415
  7. Marjan Abbassi, PHARM.DPhiladelphia, PA1366691008
  8. Sally Abbonizio, RPHWest Chester, PA1801085089
  9. Catherine AbbottPlymouth Meeting, PA1184950578
  10. Jessica Abbott, PHARM.D, RPHGreentown, PA1255654059

Common questions

What is Godlove Ebong Etape, RPH's NPI number?

Godlove Ebong Etape, RPH's National Provider Identifier (NPI) is 1932821840, issued on Sep 16, 2022. An NPI identifies a provider in billing; it is not a license.

Where is Godlove Ebong Etape, RPH located?

The NPPES record lists a practice address at 1306 Macdade Blvd, Woodlyn, PA, 19094. Phone: (610) 521-7011. Providers update this record themselves, so call before visiting.

How can I verify Godlove Ebong Etape, RPH's license?

NPPES lists Pennsylvania license number RP453087, as entered by the provider. Search the Pennsylvania board that licenses this profession; the NPPES record confirms identity only.

Source: CMS National Plan and Provider Enumeration System (NPPES), file of Aug 9, 2026 (NPPES files on CMS.gov); NUCC Health Care Provider Taxonomy. An NPI identifies who bills; it is not a license.

Figures on PlainDoctor are read from the federal files each page names (CMS NPPES, Medicare Part D, MIPS, Open Payments; the HHS-OIG exclusion list only as counts) and from Census population estimates, with the file date shown beside them. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of Aug 9, 2026.